BackNRX Pharmaceuticals- Warrants (24/05/2026) Overview
NRX Pharmaceuticals Inc - Warrants (24/05/2026)

NRX Pharmaceuticals- Warrants (24/05/2026) Return on Equity

Latest ROE for NRX Pharmaceuticals- Warrants (24/05/2026): 13811.76% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

13811.76%

Return on Equity

13811.76%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

NRX Pharmaceuticals- Warrants (24/05/2026) (NRXPW) FAQ

As of the most recent data, NRXPW shows a ROE of 13811.76%. That is above the Healthcare sector average of 20.86%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average ROE is about 20.86%. NRX Pharmaceuticals- Warrants (24/05/2026) is at 13811.76%, which is higher that average. That is roughly 66121.9% above the sector mean. Use the comparison chart on this page to see how NRXPW stacks up against individual peers as well.

Check the historical chart to see whether NRXPW's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare NRX Pharmaceuticals- Warrants (24/05/2026) with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has NRX Pharmaceuticals- Warrants (24/05/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 13811.76%) with ownership activity and broader fundamentals.

The Healthcare average ROE is about 20.86%, while NRXPW is at 13811.76%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.